Boston is a world leader in the life sciences industry, with startups and global giants alike competing for talent, as well as real estate. The past 10 years have seen tremendous growth, with the total life sciences space in Greater Boston increasing to 27 million square feet in 2021 from 17 million in 2010, with an additional 7 million SF in the development pipeline. Ever-expanding interest in the market has catapulted Greater Boston into the spotlight, ranking it as a leader among US and global life science ecosystems and becoming one of the top recipients of venture capital investment.
Jump on board the virtual NAIOP Bus Tour as Robert Coughlin, Managing Director at JLL and former CEO of MassBIO provides an overview of this booming sector, followed by a panel discussion with leading developers in the market today. After the program, attendees will receive in-depth, prerecorded, sub-market updates provided by expert brokers, spotlighting exciting new development projects.
Life Science Industry OverviewBob Coughlin, Managing Director, JLL
Panel:Bill Kane, President - East Coast and United Kingdom Markets, BioMed Realty
William McQuillan, Founding Principal, Boylston Properties
Jessica Hughes, Regional Director – Boston, Tishman Speyer
Submarket Tours:
Cambridge: Molly Heath, Managing Director, JLL
Boston: McKenna Teague, Vice President, CBRE
Urban Edge - Somerville & Watertown: Duncan Gratton, Executive Director, Cushman & Wakefield
Route 128: Nora Smith, Director, Newmark
GMP: Tim Allen, Assistant Vice President, Colliers
Tour Spotlight
451 D Street
Related Beal
Washington Village
Samuels & Associates
On the Dot
Core Investments
20 CambridgeSide
UBS & New England Development
Exchange South End
The Abbey Group
225 Wyman
Hobbs Brook
The Arsenal on the Charles
Alexandria
Innovation Park | Andover
IQHQ
Have a login? Login Now
{{vm.loginInfo.errorMessage}}
Create an Account
Forgot your Username or Password?
Register as Guest
Address
Phone
{{slot.Name}}
{{ vm.EventInfo.EventSettings.NoShowPolicy }}